We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Beta Blockers May Increase Risk during Surgery

By HospiMedica International staff writers
Posted on 12 Oct 2015
Print article
A new study suggests that patients on β-blockers face heightened risks of heart complications during non-cardiac surgeries.

Researchers at the University of Copenhagen (KU; Denmark), Rigshopitalet University Hospital (Copenhagen, Denmark) and other institutions conducted a study to determine the risk of major adverse cardiovascular events (MACEs) associated with long-term therapy for uncomplicated hypertension in patients who underwent noncardiac surgery between 2005 and 2011. In all, 14,644 patients who received β-blockers and 40,676 patients who received other antihypertensive drugs—such as thiazides, calcium antagonists, or renin-angiotensin system [RAS] inhibitors—were included in the study.

The main outcomes and measures included 30-day risk of MACEs (i.e., cardiovascular death, nonfatal ischemic stroke, nonfatal myocardial infarction (MI), and all-cause mortality). Overall, 1.3% of the patients treated with β-blockers suffered a MACE, compared with 0.8% of patients not treated with β-blockers. β-blocker use was also associated with increased risks of MACE in two-drug combinations with RAS inhibitors, calcium antagonists, and thiazides, compared to the reference combination of RAS inhibitors and thiazides; results were similar for all-cause mortality.

The researchers also found that the risk of MACE associated with β-blocker use seemed especially pronounced for patients 70 years and older and for patients undergoing acute surgery, when compared to younger patients, women, and patients undergoing elective surgery, respectively. The researchers stressed that the findings were pertinent only for people with uncomplicated high blood pressure and not those with heart problems. The study was published early online on October 5, 2015, in JAMA Internal Medicine.

“Surgery is a big stress, and the body needs to accommodate that; β-blockers put on a lid on the heart's response,” said lead author Mads Jorgensen, MD, of the University of Copenhagen. “This observation may suggest that perioperative management of patients with hypertension should receive specific attention in clinical practice and future guidelines, but additional randomized clinical trials on this question may be warranted.”

β-blockers are used for the management of cardiac arrhythmias, protecting the heart from a second MI after a first heart attack (secondary prevention), and hypertension. They block the action of the endogenous catecholamines epinephrine and norepinephrine, in particular on adrenergic beta receptors located on cells of the heart muscles, airways, arteries, and other tissues that are part of the sympathetic nervous system. They also interfere with the binding to the receptor of other stress hormones, mediating the fight-or-flight response.

Related Links:

University of Copenhagen
Rigshopitalet University Hospital


Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Vibrating Mesh Nebulizer
Aerogen Solo

Print article

Channels

Surgical Techniques

view channel
Image: The living replacement knee will be tested in clinical trials within five years (Photo courtesy of ARPA-H)

Living Knee Replacement to Revolutionize Osteoarthritis Treatment

Osteoarthritis is the most prevalent type of arthritis, characterized by the progressive deterioration of cartilage, or the protective tissue covering the bone ends, resulting in pain, stiffness, and impaired... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.